Fibrocell Science Company Profile (NASDAQ:FCSC)

Analyst Ratings

Consensus Ratings for Fibrocell Science (NASDAQ:FCSC) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $5.63 (416.06% upside)

Analysts' Ratings History for Fibrocell Science (NASDAQ:FCSC)
Show:
DateFirmActionRatingPrice TargetActions
7/6/2016Griffin SecuritiesReiterated RatingBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Roth CapitalReiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016WedbushReiterated RatingNeutral$1.50 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Canaccord GenuityReiterated RatingBuy$1.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Fibrocell Science (NASDAQ:FCSC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/5/2016Q1($0.15)($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2016Q415($0.17)($0.40)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.16)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.16)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2015($0.16)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2015($0.16)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2014Q3 14($0.14)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014($0.18)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/19/2014Q114($0.15)($0.35)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/17/2014Q414($0.26)($0.14)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Fibrocell Science (NASDAQ:FCSC)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.18)($0.14)($0.16)
Q2 20163($0.22)($0.09)($0.15)
Q3 20163($0.23)($0.06)($0.13)
Q4 20163($0.24)($0.07)($0.14)
Q1 20174($0.20)($0.07)($0.13)
Q2 20174($0.20)($0.07)($0.13)
Q3 20174($0.21)($0.05)($0.13)
Q4 20173($0.17)($0.05)($0.10)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Fibrocell Science (NASDAQ:FCSC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Fibrocell Science (NASDAQ:FCSC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
11/13/2015David PernockCEOBuy3,000$5.00$15,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2015David PernockCEOBuy3,500$6.54$22,890.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/27/2015Randal J KirkMajor ShareholderBuy975,987$5.80$5,660,724.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2015David PernockCEOBuy16,600$4.30$71,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014David PernockCEOBuy5,000$2.52$12,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2014David PernockCEOBuy5,000$2.54$12,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2014John Michael MaslowskiVPBuy1,000$2.54$2,540.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014Christine St.ClareDirectorBuy10,000$3.00$30,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014David PernockCEOBuy12,500$2.95$36,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2014Kelvin MooreDirectorBuy4,557$2.99$13,625.43View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2014Randal J KirkMajor ShareholderBuy400,000$2.90$1,160,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/24/2014Randal J KirkMajor ShareholderBuy1,024,590$4.88$4,999,999.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/21/2013David PernockCEOBuy10,000$3.69$36,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2013Gregory L WeaverCFOBuy10,000$3.51$35,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2013Randal J KirkMajor ShareholderBuy3,658,536$4.10$14,999,997.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/26/2013Randal J KirkMajor ShareholderBuy1,243,781$6.03$7,499,999.43View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Fibrocell Science (NASDAQ:FCSC)
DateHeadline
07/27/16 04:11 PMCan Shares Of Fibrocell Science Inc (NASDAQ:FCSC) Hit $12? - Investor Newswire
07/27/16 03:28 PMFibrocell Announces First Subjects Enrolled in Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa - [at noodls] - EXTON, Pa., July 27, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC) today announced that the first two adult subjects were enrolled in the Phase I/II clinical trial of FCX-007 for the treatment ...
07/27/16 03:08 PMFIBROCELL SCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
07/22/16 05:19 AMChecking in on Stock Volatility for: Fibrocell Science, Inc. (NASDAQ:FCSC) - Engelwood Daily
07/22/16 05:19 AMStock Soars, Rewards Investors Nicely Today: Fibrocell Science, Inc. (NASDAQ:FCSC) - Engelwood Daily
07/21/16 07:32 AMIs $12 Price Target Attainable For Fibrocell Science Inc (NASDAQ:FCSC)? - Investor Newswire
07/21/16 07:32 AMHow Many Fibrocell Science Inc (NASDAQ:FCSC)'s Analysts Are Bearish? - Press Telegraph
07/19/16 04:06 PMFibrocell Science Inc Stock Technicals Hit Extreme Weakness - CML News
07/19/16 04:06 PMInovio Pharmaceuticals, Inc. (NASDAQ:INO) Rose 2.36%: Fibrocell Science, Inc. (NASDAQ:FCSC), Bank of America ... - KC Register
07/19/16 04:06 PMInvestor Watch: Volatility Recap on Shares of: Fibrocell Science, Inc. (NASDAQ:FCSC) - Engelwood Daily
07/19/16 04:06 PMFibrocell Science Inc (FCSC) Broker Price Targets For The Coming Week - Fiscal Standard
07/19/16 04:06 PMShares Losing Ground in Session: Fibrocell Science, Inc. (NASDAQ:FCSC) - TGP
07/19/16 11:24 AMETF’s with exposure to Fibrocell Science, Inc. : July 19, 2016 -
07/16/16 07:24 AMShares Experiencing a Downtrend: Fibrocell Science, Inc. (NASDAQ:FCSC) - TGP
07/15/16 05:28 AMEye on Stock Volatility for: Fibrocell Science, Inc. (NASDAQ:FCSC) - Engelwood Daily
07/15/16 05:28 AMFibrocell Science Incorporated (NASDAQ:FCSC) Short Interest Decreased By 24.38% - Consumer Eagle
07/14/16 07:13 AMFibrocell Science Inc (NASDAQ:FCSC) Institutional Investor Sentiment Trend - Consumer Eagle
07/14/16 07:13 AMStrong Sell Calls For Fibrocell Science Inc (NASDAQ:FCSC) At 0 - Investor Newswire
07/12/16 09:20 PMAre Analysts Bearish Fibrocell Science Inc (NASDAQ:FCSC) After Last Week? - Consumer Eagle
07/12/16 04:11 PMFIBROCELL SCIENCE, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
07/11/16 03:58 PMGilead's Pan-Genotypic HCV Drug Epclusa Gains EU Approval
07/11/16 08:46 AMNext Weeks Broker Price Targets For Fibrocell Science Inc (FCSC) - Fiscal Standard
07/11/16 07:04 AMAmgen Humira Biosimilar Briefing Documents Look Good -
07/07/16 03:31 PMFibrocell to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference - [at noodls] - EXTON, Pa., July 07, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc., (NASDAQ:FCSC) today announced that David Pernock, Chairman and Chief Executive Officer of Fibrocell, will present at Cantor Fitzgerald's ...
07/07/16 05:28 AMFibrocell Science Inc (NASDAQ:FCSC) Expected to Reach Highs Of $12 - Investor Newswire
07/05/16 08:41 AMThis Weeks Broker Price Targets For Fibrocell Science Inc (FCSC) - Fiscal Standard
07/01/16 06:01 AMFibrocell Science Incorporated (NASDAQ:FCSC) Short Interest Decreased By 24.38% - Press Telegraph
06/30/16 04:14 PMChester County gene therapy company cuts its workforce in half
06/30/16 04:14 PMFibrocell Science : Expects Significant Cost Savings from Wind-Down of azficel-T Operations
06/30/16 05:47 AMAnalyst Rating Update on Fibrocell Science Inc (FCSC) - TheFounders Daily
06/29/16 08:58 PMWatching Stock Volatility for: Fibrocell Science, Inc. (NASDAQ:FCSC) - Engelwood Daily
06/29/16 08:58 PMFibrocell Science (FCSC) Updates on Azficel-T Wind-Down; Expects 'Significant' Cost Savings - StreetInsider.com
06/29/16 08:58 PMStock Tracking Lower in Session: Fibrocell Science, Inc. (NASDAQ:FCSC) - Telanagana Press
06/29/16 03:56 PMFibrocell Expects Significant Cost Savings from Wind-Down of azficel-T Operations
06/29/16 05:52 AMHC Stocks Impression: Fibrocell Science Inc (NASDAQ:FCSC), Pfizer Inc. (NYSE:PFE) - share market updates (press release)
06/28/16 03:57 PMChecking on Unusual Volume for: Fibrocell Science, Inc. (NASDAQ:FCSC) - Engelwood Daily
06/28/16 03:57 PMWatch List: Fibrocell Science, Inc. (NASDAQ:FCSC), Cobalt International Energy, Inc. (NYSE:CIE), Alcoa Inc. (NYSE:AA ... - KC Register
06/28/16 03:57 PMTraders Alert: ON Semiconductor Corp (NASDAQ:ON), Fibrocell Science Inc (NASDAQ:FCSC) - NYSE Journal (press release)
06/28/16 03:57 PMAnalysis under consideration: Fibrocell Science, Inc. (NASDAQ:FCSC) - News Oracle
06/28/16 03:57 PMStocks Analysts Ranking Summary: Fibrocell Science Inc (NASDAQ:FCSC) , GW Pharmaceuticals Plc (NASDAQ:GWPH) - Street Updates
06/27/16 04:10 PMFIBROCELL SCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vot -
06/27/16 02:24 PMETF’s with exposure to Fibrocell Science, Inc. : June 27, 2016 -
06/24/16 04:03 PMStock in Oversold Area: Fibrocell Science, Inc. (NASDAQ:FCSC) - Press Telegraph
06/24/16 04:03 PMShares Dropping to a Recent Low: Fibrocell Science, Inc. (NASDAQ:FCSC) - Press Telegraph
06/23/16 04:46 AMStrong Buy Calls Count For Fibrocell Science Inc (NASDAQ:FCSC) At 2 - Investor Newswire
06/16/16 04:00 PMFibrocell Science Inc. (NASDAQ: FCSC) Kicks The Ball Rolling On FCX-007 - Scibility Media
06/13/16 03:46 PMFibrocell Science (FCSC) Commences Recruitment for FCX-007 Phase 1/2 as RDEB Treatment - StreetInsider.com
06/09/16 04:01 PMMarket Moving Stocks Update: Fibrocell Science, Inc. (NASDAQ:FCSC), Amazon.com, Inc. (NASDAQ:AMZN) - Beacon Chronicle
06/09/16 06:47 AMFDA Panel Nod For PFE, INSM Withdraws MAA, FCSC's Voice Fades Out
06/08/16 04:11 PMFibrocell: Phase 2 Azficel-T Vocal Cord Scarring Trial Fails To Meet Targets

Social

About Fibrocell Science

Fibrocell Science logoFibrocell Science, Inc. is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue and joints. Its product candidate, azficel-T, is in development to treat patients suffering from vocal cord scarring that is either idiopathic or age-related. It is investigating the indication in a Phase II clinical trial. Its gene-therapy product candidate, FCX-007, is in pre-clinical development for the treatment of recessive dystrophic epidermolysis bullosa. Its gene-therapy product candidate, FCX-013, is in pre-clinical development for the treatment of linear scleroderma. Its product, LAVIV (azficel-T), is indicated for the improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. A third gene-therapy program is focused on the treatment of arthritis. Its product, LAVIV (azficel-T), is focused on improving the appearance of nasolabial fold wrinkles in adults.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: FCSC
  • CUSIP:
Key Metrics:
  • Previous Close: $1.09
  • 50 Day Moving Average: $1.15
  • 200 Day Moving Average: $2.15
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $47.85M
  • Beta: 0.52
  • Current Year EPS Consensus Estimate: $-0.46 EPS
  • Next Year EPS Consensus Estimate: $-0.41 EPS
Additional Links:
Fibrocell Science (NASDAQ:FCSC) Chart for Wednesday, July, 27, 2016